✦ LIBER ✦

NIC5-15 as a treatment for Alzheimer's disease: Results of a Phase 1 pharmacokinetic and feasibility study

✍ Scribed by Hillel Grossman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NIC5-15 as a treatment for Alzheimer's:

✍ Hillel Grossman; George Marzloff; Xiaodong Luo; Derek LeRoith; Mary Sano; Giulio 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

P.5.a.007 Aβ AFFITOPES as active vaccine

✍ A. Kutzelnigg; A. Schneeberger; M. Brunner; D. Meshkat; P. Dai-Bianco; A. Laggne 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 98 KB

1-42-05 Clinical studies of metrifonate

✍ F. Bieber; D. Meulien; I. Ouvry; O. Collins; J. Curram; F. Gibbons; M. Gleeson 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 328 KB

Docetaxel, 5-fluorouracil, and leucovori

✍ Manuel Constenla; Ramon Garcia-Arroyo; Isabel Lorenzo; Nancy Carrete; Begoña Cam 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 78 KB

Pharmacokinetics, safety and tolerabilit

✍ Nicholas, Timothy; Raunig, David; Duvvuri, Sridhar; Plotka, Anna; Schwam, Elias; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 83 KB

The ability to design a proxy for consen

✍ Sarah Benisty; Marc Verny; Catherine Thomas-Anterion; Christine Perret-Guillaume 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB